LB Abnoba focuses on oncology and immunotherapy based on cognitive medicine, introducing various pharmaceuticals through joint research and technology partnerships with leading global pharmaceutical companies. Through a technology partnership with Germany’ s Abnoba GmbH, we have introduced the natural immune-oncology agent Abnobaviscum to the Korean market. In addition, we supply the non-hormonal menopause prescription drug Klimadophlan Tablets under an exclusive sales agreement with Germany’ s DHU. We have also introduced Lbracan, a breast cancer treatment, as the only domestically manufactured product of its kind in Korea, presenting new possibilities in cancer and immunotherapy. LB Abnoba continues to strengthen strategic partnerships with global pharmaceutical companies to introduce differentiated and innovative new products.












